WASHINGTON – In response to the government’s agenda to expand the booster campaign to more vaccinated Americans, Johnson & Johnson requested the Food and Drug Administration to allow them to administer extra booster shots to Americans.
J&J continues to respond to President Biden’s agenda to increase protection against the surging COVID-19 delta variant.
The Food and Drug Administration received the company’s request to administer booster shots to people 18 and older. Despite receiving acceptable results on several booster intervals, the company did not recommend it to the regulators.
The FDA has already approved the Pfizer vaccine for older Americans and those with high vulnerabilities to COVID-19.
However, despite the government supporting the Pfizer booster shots, there is still confusion between the Americans. The government still discourages the public from mixing their vaccines with other vaccine brands.
The FDA will invite different experts next week to begin reviews on both Johnson & Johnson and Moderna. The review process will end with the sign-off from both the FDA and the Centers for Disease Control and Prevention.
If both departments approve the vaccines, the government will start releasing the Johnson & Johnson and Moderna booster shots to the public.
The J&J vaccine continues to show good results in its efficacy against COVID-19, totaling at least an 81% effectiveness rate against infection.
The J&J booster shot shows a 94% effectiveness rate against modern-to-severe COVID-19 infection. The data significantly shows increased immunity by at most six months.
Pfizer and Moderna continue to provide most of the US COVID-19 vaccines.
